Navigation Links
Rutgers part of team awarded $3.3 million National Institutes of Health grant for prostate cancer research
Date:10/10/2010

NEW BRUNSWICK, N.J. The National Institutes of Health has awarded a $3.3 million grant to a research team that includes Rutgers University to increase the reliability of imaging prostate cancer.

The team, led by Riverside Research Institute and involving clinicians from Boston's Beth Israel Deaconess Medical Center and engineers at GE Global Research, will research ways to help urologists zero in on suspicious tissue in the prostate gland while they perform needle biopsies or localized treatments for prostate cancer.

The National Institutes of Health (NIH) awarded the grant under its industrial-academic partnership program to fund work that can quickly move from the research lab to patient care.

The researchers are developing technology to pinpoint the locations of suspected cancerous tissue using both magnetic resonance images acquired just before the biopsy or treatment and ultrasound images acquired at the time of the procedure.

Currently, urologists typically use conventional ultrasound images to guide them to various regions of the prostate gland, from which they extract samples of tissue. While conventional ultrasound can image the gland well, it cannot reveal the presence or location of suspicious tissue inside the gland. If the biopsy samples don't yield cancerous tissue, there's still a chance that cancer is present.

"As a result, urologists aren't always confident about ruling out cancer after a negative biopsy guided by conventional ultrasound," said Anant Madabhushi, associate professor of biomedical engineering at Rutgers and co-investigator on the NIH grant.

The research team aims to combine advanced ultrasound and magnetic resonance (MR) technologies developed by the consortium's researchers to provide a more reliable method of imaging prostate cancer than is possible using either advanced method alone.

"The information we glean from combining the two methods could help urologists d
'/>"/>

Contact: Carl Blesch
cblesch@ur.rutgers.edu
732-932-7084 x616
Rutgers University
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. NIH awards Rutgers $47.5 million to advance groundbreaking research on protein structures
2. Rutgers-Camden professor engineers E. coli to produce biodiesel
3. Rutgers researchers assess severity of prostate cancers using magnetic resonance imaging
4. Rutgers researchers discover secrets of nutritious corn breed that withstands rigors of handling
5. Rutgers cell biologist pinpoints how RNA viruses copy themselves
6. NSF grant supports Rutgers-Camden program for science majors
7. TAXIS Pharmaceuticals licenses novel antimicrobial technology from Rutgers and UMDNJ
8. Rutgers to collaborate in $3.4 million effort to improve prostate cancer identification using MRI
9. Rutgers-Camden developing enzyme function database
10. Rutgers research tackles childhood epilepsy
11. Rutgers study finds many consumers ignore food product recalls
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/11/2015)... , May 11, 2015 Curemark LLC, a ... start of a new Phase III double blind, randomized, ... novel formulation, CM-AT, on all children ages 3-8 with ... FDA Phase III double blinded clinical trial for CM-AT ... levels of the digestive enzyme chymotrypsin. This new trial ...
(Date:5/8/2015)... 2015 Synaptics Inc. (NASDAQ: SYNA ), the ... of the executive management team will present at the following ... and Telecom Conference Date: May 18, 2015 Time: ... MA Cowen and Company Technology, Media ... Location: The New York Palace Hotel, New York, ...
(Date:5/6/2015)... 2015 LifeBEAM, a developer of bio-sensing technology, ... today that they will expand their partnership in bio-sensing ... cycling helmet and the first joint project between the ... in order to give cyclists more style choices and ... and Lazer announced their plan to release a new ...
Breaking Biology News(10 mins):Curemark, LLC, Launches New Phase III Trial in Expanded Population of Children with Autism 2Synaptics to Present at Upcoming Investor Conferences 2LifeBEAM and Lazer Announce Expanded Partnership in Bio-Sensing Sports Gear 2LifeBEAM and Lazer Announce Expanded Partnership in Bio-Sensing Sports Gear 3
... Yamanaka MD, PhD, of Kyoto University and the Gladstone ... forward in improving the possibilities for the practical application ... Dr. Yamanaka had shown that adult cells can be ... oncogene as one of the four genes required to ...
... Jim Doyle today announced a historic collaboration between ... care leading to health care that proactively addresses ... research effort among the Marshfield Clinic, Medical College ... Medicine and Public Health (UWSMPH) and UW-Milwaukee (UWM). ...
... one of the most thoroughly studied organisms in the ... understanding variation in physiology, behavior, life history and morphology ... On biological levels from molecular and genetic to developmental ... it has proven far more complex than even imagined. ...
Cached Biology News:Yamanaka eliminates viral vector in stem cell reprogramming 2Governor Doyle announces historic genomic research collaboration 2Fitness in a changing world 2Fitness in a changing world 3
(Date:5/28/2015)... , May 28, 2015  PDS Biotechnology ... cancer immunotherapy treatment targeting HPV-16, has generated strong ... Currently, pre-cervical cancer is treated by surgical ... simple and effective non-surgical alternative. Results show that ... (T-cells) to recognize, target, and kill precancerous and ...
(Date:5/28/2015)... The Fertility Centers of New England is proud to ... on a new and expanded role as Medical Director. ... oversight and quality assurance for the practice. , “We ... of experienced reproductive endocrinologists,” said Fertility Centers of New ... expertise and compassionate, individualized care have helped set FCNE ...
(Date:5/28/2015)... Rochelle, Virginia (PRWEB) May 28, 2015 ... Partners LLC announced today that Roger L. Williams, ... Expert consultant. NDA Partners Premier Experts are top ... them to bring extraordinary value to the company’s ... critical solutions to help clients successfully develop their ...
(Date:5/27/2015)... 26, 2015 Research and Markets ... of Jain PharmaBiotech,s new report "Molecular ... to their offering. This report ... that will play an important role in ... forensics and biological warfare in the 21st ...
Breaking Biology Technology:PDS Biotechnology reports positive Phase I clinical trial results in proprietary HPV-Cancer Immunotherapy 2Danielle Vitiello, MD of Fertility Centers of New England, Named New Medical Director 2Former CEO and Chair of the Council of Experts at the USP, Roger L. Williams, MD, Joins NDA Partners as a Premier Expert Consultant 2Global Molecular Diagnostics Market 2015-2024 - Analysis of Key Technologies, Markets and Companies 2Global Molecular Diagnostics Market 2015-2024 - Analysis of Key Technologies, Markets and Companies 3
... Osaka, Japan, for the Bio Japan 2006 conference as ... of times over the years about both the Japanese pharma and ... few years and I'm looking forward to getting up to speed ... reminder: Chicago and Osaka are sister cities and my last visit ...
... EraGen Biosciences , a Madison-based developer of diagnostic ... outline its product development plans. , ,Irene Hrusovsky, CEO ... of the company to attendees of the Mid-America ... of ZyStor Therapeutics, Inc. , a Milwaukee-based developer ...
... other TV news broadcasts, the accusation that Hewlett ... of directors was revealed. Because she was afraid that ... Patricia Dunn, unilaterally authorized a project headed up by ... personal phone records of board members. www.msnbc.msn.com/id/14687677/site/newsweek ...
Cached Biology Technology:Chinese pharma-biotech dragon rears its head 2Chinese pharma-biotech dragon rears its head 3Chinese pharma-biotech dragon rears its head 4Chinese pharma-biotech dragon rears its head 5Chinese pharma-biotech dragon rears its head 6EraGen set to highlight diagnostic products at BIO 2Compliance at HP - Pretexting paranoia 2Compliance at HP - Pretexting paranoia 3Compliance at HP - Pretexting paranoia 4Compliance at HP - Pretexting paranoia 5
The Bio-Plex Manager version 3.0 to 4.0 workstation software upgrade kit is used to upgrade existing Bio-Plex Manager version 3.0 software to version 4.0 security edition software....
... --- a cocktail of 3 siRNAs specifically ... our most popular product. The siTrio reagent ... of your target gene when used under ... and confirmation of optimal transfection with one ...
... Spring offers a large collection of ... fetal tissuea, cell lines, and mouse ... in pHD9 vector. The size of ... be from 200bp to 1000bp by ...
... #27295 has improved stability and convenience from the ... only has overcome this problem but also produced ... changed the formulation of HRP conjugated antibody from ... this change, the stability of the conjugate has ...
Biology Products: